Intrathecal baclofen and motor function in cerebral palsy
نویسندگان
چکیده
منابع مشابه
Cerebral Palsy: Motor Types, Gross Motor Function and Associated Disorders
Objectives: Cerebral palsy (CP) describes a group of disorders in the development of movement and posture in the developing brain. The main aim of this study was to determine the distribution of motor impairment and associated disorders in a population of children with CP. Methods: This study was carried out in 2011 during three months, on 200 CP children. Multiple sources of ascertainment w...
متن کاملcerebral palsy: motor types, gross motor function and associated disorders
objectives: cerebral palsy (cp) describes a group of disorders in the development of movement and posture in the developing brain. the main aim of this study was to determine the distribution of motor impairment and associated disorders in a population of children with cp. methods: this study was carried out in 2011 during three months, on 200 cp children. multiple sources of ascertainment were...
متن کاملQuality of Life and Gross Motor Function in Children with Cerebral Palsy (Aged 4-12)
Objectives: Most definitions equate Quality of Life with motor function. The aim of this study is to examine the association between gross motor function and Quality of Life for children with cerebral palsy. Methods: In this analytical cross–sectional study, 60 children with cerebral palsy aged 4-12 were selected through convenience sampling based on inclusion criteria from occupationa...
متن کاملOutcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury
Intrathecal baclofen (ITB) has been known to reduce spasticity which did not respond to oral medications and botulinum toxin treatment. However, few results have been reported comparing the effects of ITB therapy in patients with cerebral palsy (CP) and acquired brain injury. This study aimed to investigate beneficial and adverse effects of ITB bolus injection and pump therapy in patients with ...
متن کاملIntrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial
BACKGROUND Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. Despite this widespread adoption, high quality evidence on the effects of intrathecal baclofen treatment o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Developmental Medicine & Child Neurology
سال: 2011
ISSN: 0012-1622
DOI: 10.1111/j.1469-8749.2011.03921.x